Status:

COMPLETED

Tuberculosis (TB) Aftermath

Lead Sponsor:

Johns Hopkins University

Collaborating Sponsors:

National Institute of Allergy and Infectious Diseases (NIAID)

Dr. D.Y. Patil Medical College, Hospital and Research Centre

Conditions:

Tuberculosis (TB)

Eligibility:

All Genders

18-99 years

Phase:

NA

Brief Summary

TB Aftermath will compare effectiveness, cost-effectiveness and feasibility of two ACF strategies for detecting recurrent TB and provide evidence needed to implement and scale the preferred ACF strate...

Detailed Description

Approximately 7% of all reported tuberculosis (TB) cases each year are recurrent, occurring among people who have had TB in the recent or distant past. TB recurrence is particularly common in India, w...

Eligibility Criteria

Inclusion

  • Those who are registered at one of the study TB Units (TUs) in Pune district as treatment completed or cured (regardless of type of TB or duration of treatment).
  • Confirmed treatment completion or cure status by the referring medical officer of the study TU.
  • Date of treatment completion within 60 days of date of enrolment.
  • Ability and willingness of participant or legal guardian/representative to provide informed consent to participate in the home-based ACF (HACF) or telephonic ACF arm (TACF).
  • (NOTE: Illiterate participants or participants with cognitive disabilities may be enrolled based on local regulatory policies, with the appropriate provisions for informed consent.)
  • \- All household contacts of TB cases who are able and willing to provide informed consent to participate are eligible. Household contacts who are \<18 years old are eligible for enrolment if a legal guardian/representative provides informed consent.

Exclusion

  • Completed anti-TB treatment at a private sector clinic or TU outside of the study (final visit not registered at one of the study TB units)
  • Actively on anti-TB treatment

Key Trial Info

Start Date :

January 29 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2025

Estimated Enrollment :

3094 Patients enrolled

Trial Details

Trial ID

NCT04333485

Start Date

January 29 2021

End Date

June 1 2025

Last Update

August 1 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Dr. D.Y. Patil Medical College, Hospital and Research Centre

Pune, Maharashtra, India, 411018